Westphal et al16 firstly reported that transgenic mice with cardiomyocyte‐specific overexpression of CYP2J2 enhanced cardiac EET biosynthesis, reducing ventricular tachyarrhythmia and AF susceptibility during maladaptive cardiac hypertrophy. Here, CYP2J2 is linked to cardiac hypertrophy.